VANCOUVER, British Columbia, Jan. 2, 2017 /Weed Wire/ — Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: TGIFF) is pleased to announce that it has entered into a land purchase agreement to acquire an additional 2.78 acres of land connected to the location that will host Alternative Medicine Association’s new cultivation facility.
Tag Archives: OTC
Friday Night Inc. Signs Production Agreement with Nevada Dispensary
VANCOUVER, British Columbia, Dec. 6, 2017 /Weed Wire/ – Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: TGIFF) is pleased to announce that Alternative Medicine Association (“AMA”) has signed a production contract to produce high-grade concentrates for a major dispensary chain in Nevada.
Friday Night Inc. Reports 2017 Annual Results
VANCOUVER, British Columbia, Nov. 29, 2017 /Weed Wire/ — Friday Night Inc. (“Friday Night” or the “Company”) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) announces audited year-end financials for the year ended July 31, 2017.
United Nations Invites Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Executive to Speak at World Health Organization Convention in Geneva, Switzerland
SAN DIEGO, Oct. 26, 2017 /Weed Wire/ – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico Executive Raúl Elizalde has been invited to speak on behalf of the family of companies, to the U.N. at the World Health Organization’s (WHO) International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs in Geneva, Switzerland, on Nov. 6, 2017.
DirectView Inks Full Servicing Contract for Top-Tier Marijuana Cultivator
NEW YORK, Oct. 25, 2017 /Weed Wire/ – DirectView Holdings, Inc. (OTC:DIRV) (“DirectView” or the “Company”), a company focused on ownership and management of leading video and security technology companies, announced today that the company’s operations now adjoin with the $7.8 billion cannabis industry as a premier supplier of security equipment and infrastructure tailored for cultivators.
Global Hemp Group & Marijuana Company of America To Form Joint Venture With Space Cowboys’ Colorado Farms
VANCOUVER, British Columbia, Oct. 10, 2017 /Weed Wire/ — GLOBAL HEMP GROUP (“GHG” or the “Company”) (CSE:GHG / FF:GHG / OTC:GBHPF) an industrial hemp and cannabis corporation, and Marijuana Company of America, Inc. (“MCOA”), (collectively the “Companies”), are pleased to announce they have jointly entered into a letter of intent with Space Cowboys, Inc.
Friday Night Inc. Signs Exclusive License with Legendary Hip-Hop Artist, Kurupt
VANCOUVER, British Columbia, Sept. 29, 2017 /Weed Wire/ — Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) is pleased to announce that the Company has entered into an exclusive licensing transaction with legendary hip-hop artist, Kurupt.
American Green Successfully Completes Transaction for the Purchase of Nipton, CA, Ahead of Schedule
PHOENIX, Ariz., Sept. 19, 2017 /Weed Wire/ — Today American Green, Inc. (OTC: ERBB) has announced that after the necessary time to crystalize the first phase of its multi-year plan, it has started working in and around Nipton with locals and visiting specialists alike.
Friday Night Inc. Enters into a Land Purchase Agreement
VANCOUVER, British Columbia, Aug. 28, 2017 /Weed Wire/ — Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) is pleased to announce that it has entered into a land purchase agreement in Nevada.
It’s All Going to Pot: American Green Buys Town of Nipton in California
The great Willie Nelson once said that it’s all going to pot, but what he may not have realized is that it would start in Nipton, California. On Aug. 4, 2017, the company American Green (OTCPK:ERBB) announced that it had purchased Nipton with the intention of turning it into the first marijuana-friendly tourist destination.
American Green Inc. Purchases Town of Nipton, California, with Plans to Develop Premier Cannabis Hospitality Destination
PHOENIX, Ariz., Aug. 1, 2017 /Weed Wire/ — Today American Green, Inc. (ERBB:OTC) has announced its purchase of the town of Nipton, California, a 100-year-old community in San Bernardino county, and intends to modernize it into the country’s first energy-independent, cannabis-friendly hospitality destination.
Friday Night Inc. Meets High Demand in Nevada via New Distribution Agreement with Blackbird Logistics
VANCOUVER, British Columbia, July 21, 2017 /Weed Wire/ — Mr. Brayden Sutton, President and CEO of Friday Night Inc., (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF), is pleased to provide an update on the progress of the company’s 91% owned asset, Alternative Medicine Association, LC.
Marijuana Company of America (MCOA) Receives Financing for Joint Venture in Washington State
ESCONDIDO, Calif., July 19, 2017 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative cannabis and hemp marketing and distribution Company, is pleased to announce that it has contributed the first installment of capital to Bougainville Ventures, Inc.
Two Marijuana Stocks Suspended Temporarily by SEC
On May 19, 2017, the U.S. Securities and Exchange Commission announced the temporary suspension of two marijuana stocks that trade on the OTC Markets, with both orders of suspension related to the companies neglecting to provide accurate and up-to-date information.
SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00
SAN DIEGO, Calif., May 17, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage initiation from SeeThruEquity, a leading independent equity research firm focused on smallcap and microcap public companies, with a price target of $17.00.
Alternate Health Announces First-Ever American Medical Association-Approved Cannabis and Chronic Traumatic Encephalopathy Treatment for Continuing Medical Education Accreditation
TORONTO, Ontario, May 11, 2017 /Weed Wire/ — Alternate Health Corp (CSE:AHG) (OTC:AHGIF) announced today that its Continuing Medical Education (CME) program for doctors on Chronic Traumatic Encephalopathy (CTE) and Cannabis has been approved and accepted by the Accreditation Council for Continuing Medical Education (ACCME) in partnership with the American Medical Association (AMA).
Alternate Health Corp Reports Full Year 2016 Financial Results
DALLAS, Texas, May 8, 2017 /Weed Wire/ – Alternate Health Corp. (CSE: AHG and OTC: AHGIF), a diverse healthcare company that uses its expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry, today announced its results for the full year ending December 31, 2016.
Leafbuyer Technologies, Inc. Announces Effectiveness of Forward Split
GREENWOOD VILLAGE, Colo., May 4, 2017 /Weed Wire/ — Leafbuyer Technologies, Inc. (OTC: LBUY) announced today the effectiveness of the 9.25 for 1 forward split of its common stock is upon the open of trading May 5th, 2017 and the stock will begin trading on a split-adjusted basis.
Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol
SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.
Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications
NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,
Alternate Health Corp. Announces Closing of a CAD $7.5M Non-Brokered Private Placement
PLANO, Texas, March 13, 2017 /Weed Wire/ — Alternate Health Corp. (CSE:AHG, OTC:ATEHF) (the “Company”) is pleased to announce that it closed on March 6, 2017, a non-brokered private placement with gross proceeds of CAD$7,569,055 less finder’s fees of CAD$259,330.50.
Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum
NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.
Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown
SAN DIEGO, Calif., March 1, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by recent statements from Trump administration officials hinting at a crackdown on recreational marijuana.
Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™
SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.
Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty
SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.
Marijuana Index Review: United States and Canada Cannabis Market
Marijuana Index Review for 2017, United States and Canada Medical Cannabis Market website and it’s different features for stocks, and my input on investing.
Medical Marijuana Inc. Subsidiary Kannaway® Announces Launch of a New Product— “Kannaway® Gold Premium Hemp Oil”
SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.
Cannabis Science Stock Chart Technical Analysis
Cannabis Science Inc (OTC:CBIS) — Stock Chart Technical Analysis for Jan. 23, 2017.
Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient
SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.
AXIM Biotech Enters IBS Clinical Trial for Canchew CBD Chewing Gum
NEW YORK, Jan. 18, 2017 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has entered clinical trials on treating irritable bowel syndrome (IBS) with the Company’s CanChew Plus® cannabidiol (CBD) gum at Wageningen University in the Netherlands.
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia
SAN DIEGO, Jan. 13, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend.
Veritas Announces Private Placement
Veritas Pharma Inc. (the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), is pleased to announce that a non-brokered private placement offering of up to 9,090,910 units (“Units”) at a price of $0.22 per Unit for aggregate gross proceeds of up to $2,000,000 (the “Offering”).
Medical Marijuana, Inc. Subsidiary, HempMeds(R) Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR
Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.
Marijuana Company of America Has Engaged Auditing Firm to Prepare for Move to Fully Reporting Public Company
BONSALL, Calif., Dec. 27, 2016 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA INC., (“MCOA” or the “Company”) (OTC: “MCOA”), an innovative cannabis and hemp marketing, consulting and distribution company, has engaged L&L CPAs, PA as its independent audit firm to complete a two-year audit of the Company’s financial statements as part of the process of preparing to become a fully reporting public company with the intent of uplisting to a higher reporting exchange.
Marijuana Company of America Transitions From the Development Stage to a Revenue Generating Company
BONSALL, Calif., Nov. 17, 2016 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA INC., announced that after many months of research and product development and business planning, MCOA has now commenced generating revenue and started to ship orders for its hempSMART BRAIN product.
Veritas Announces an Expansion to the Private Placement and Engages European Healthcare Capital
VANCOUVER, British Columbia, Nov. 16, 2016 /Weed Wire/ — Veritas Pharma Inc. has expanded the private placement offering announced on September 16th.
Sipp Industries Enters Strategic Partnership for Launch of “Major Hemp Brown Ale”, Exclusive Premium Hemp Beer
COSTA MESA, Calif., Nov. 14, 2016 /Weed Wire/ — Sipp Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in technology, manufacturing, and distribution of commercial and consumer products is pleased to announce the Company has officially executed an agreement with the distinguished Denver based contract brewery, Sleeping Giant Brewing Company.
Marijuana Company of America Q4 2016 Outlook and Update
BONSALL, Calif., Oct. 18,2016 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA INC., is providing this update to keep our shareholders and prospective investors informed.
Investors Seek High Returns in Marijuana Stocks
For investors, the rising prospects of legalized pot may be too good to pass up, yet the publicly traded cannabis companies may not be such a smart bet.
New Colombia Resources Forming Joint Venture to Apply for an Orphan Drug Designation with the Food and Drug Administration (FDA) for a Medical Cannabis Pharmaceutical Product
BARRANQUILLA, Colombia, Oct. 14, 2016 /Weed Wire/ — New Colombia Resources, Inc.(OTC: NEWC) (the “Company”), a U.S. listed Colombian resource company with premium metallurgical coal and medical marijuana assets, announced they will be applying for an orphan drug designation with their collaboration partners for regulatory agency approvals of a cannabinoid pharmaceutical product for multiple medical indications.
Golden Leaf Holdings Ltd Common Shares Approved for Inclusion on the OTCQB Market
Oct. 5, 2016 /Weed Wire/ — Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH)(CSE:GLH.CN), a leading cannabis oil solutions company built around recognized brands, is pleased to announce that the OTC Markets Group has approved the Company’s common shares for listing on its OTCQB Market beginning on Wednesday, October 5, 2016.
Marijuana Company of America Announces PreLaunch of HempSMART™ Brain: A Hemp Derived CBD Product to Support Brain Function
BONSALL, Calif., Oct. 4, 2016 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC: MCOA), an innovative cannabis and hemp marketing and distribution company, is pleased to announce the prelaunch of the hempSMART Brain product has commenced.
Marijuana Company of America Launches Online Investor Relations Program With AGORACOM
BONSALL, Calif., Sept. 6, 2016 /Weed Wire/ — MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, is pleased to announce that it has retained the services of AGORACOM Investor Relations to provide online investor relations services.
Laguna Blends Closes First Tranche of Private Placement for $406,800
KELOWNA, British Columbia, Aug. 26, 2016 /Weed Wire/ — Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Laguna”) is pleased to announce a first tranche closing of its it non-brokered private placement (the “Private Placement”).
Veritas Reaches Important Scientific Milestone; Animal Studies Fully Underway to Evaluate the Safety and Effectiveness of Cannabis Strains
VANCOUVER, Aug. 10, 2016 /Weed Wire/ — Veritas Pharma Inc. announced the Company has initiated its crucial next phase of research and development, commencing functional pharmacological evaluations in rodents related to multiple cannabis strains.
Veritas Pharma Embarks on Important Next Phase of Cannabis Research
VANCOUVER, Aug. 3, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that through Cannevert Therapeutics Ltd, Veritas’ research arm, has developed several candidate cannabis strains and is now fully engaged in chemical and biological assessment of these key strains.
Veritas Provides Investor Update
VANCOUVER, British Columbia, July 18, 2016 /Weed Wire/ — Veritas Pharma Inc. (OTC: VRTHF) (CSE:VRT) (“VRT” or the “Company”) (Frankfurt: 2VP) is pleased to announce a corporate update.
Recent Developments in Cannabis Stocks
There have been some developments in a handful of cannabis related companies in the past few days.
Sipp Industries Announces Launch of Branded Hemp and CBD Products for the Equine Industry
COSTA MESA, Calif., June 23, 2016 /Weed Wire/ — Sipp Industries, Inc. (OTC: SIPC), a diversified conglomerate corporation specializing in technology, manufacturing and distribution of commercial and consumer products announces the launch of its uniquely branded hemp and CBD (cannabidiol) products specifically developed for the equine industry.
SEC Charges ‘King Of Pot’ With Investment Fraud
Federal securities regulators have filed a complaint against Bruce Perlowin that charges the CEO of publicly-traded Hemp Inc of committing a long-running fraud by evading securities registration provisions and selling hundreds of millions of unregistered shares.